Literature DB >> 26216892

B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens.

Rahul Shinde1, Michiko Shimoda1, Kapil Chaudhary1, Haiyun Liu1, Eslam Mohamed1, Jillian Bradley1, Sridhar Kandala1, Xia Li2, Kebin Liu2, Tracy L McGaha3.   

Abstract

Humoral responses to nonproteinaceous Ags (i.e., T cell independent [TI]) are a key component of the early response to bacterial and viral infection and a critical driver of systemic autoimmunity. However, mechanisms that regulate TI humoral immunity are poorly defined. In this study, we report that B cell-intrinsic induction of the tryptophan-catabolizing enzyme IDO1 is a key mechanism limiting TI Ab responses. When Ido1(-/-) mice were immunized with TI Ags, there was a significant increase in Ab titers and formation of extrafollicular Ab-secreting cells compared with controls. This effect was specific to TI Ags, as Ido1 disruption did not affect Ig production after immunization with protein Ags. The effect of IDO1 abrogation was confined to the B cell compartment, as adoptive transfer of Ido1(-/-) B cells to B cell-deficient mice was sufficient to replicate increased TI responses observed in Ido1(-/-) mice. Moreover, in vitro activation with TLR ligands or BCR crosslinking rapidly induced Ido1 expression and activity in purified B cells, and Ido1(-/-) B cells displayed enhanced proliferation and cell survival associated with increased Ig and cytokine production compared with wild-type B cells. Thus, our results demonstrate a novel, B cell-intrinsic, role for IDO1 as a regulator of humoral immunity that has implications for both vaccine design and prevention of autoimmunity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26216892      PMCID: PMC4546929          DOI: 10.4049/jimmunol.1402854

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Regulation of plasma-cell development.

Authors:  Miriam Shapiro-Shelef; Kathryn Calame
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.

Authors:  Lauren M F Merlo; Elizabeth Pigott; James B DuHadaway; Samantha Grabler; Richard Metz; George C Prendergast; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

3.  Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition.

Authors:  Hao-Yuan Jiang; Ronald C Wek
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

4.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

5.  Aryl hydrocarbon receptor control of a disease tolerance defence pathway.

Authors:  Alban Bessede; Marco Gargaro; Maria T Pallotta; Davide Matino; Giuseppe Servillo; Cinzia Brunacci; Silvio Bicciato; Emilia M C Mazza; Antonio Macchiarulo; Carmine Vacca; Rossana Iannitti; Luciana Tissi; Claudia Volpi; Maria L Belladonna; Ciriana Orabona; Roberta Bianchi; Tobias V Lanz; Michael Platten; Maria A Della Fazia; Danilo Piobbico; Teresa Zelante; Hiroshi Funakoshi; Toshikazu Nakamura; David Gilot; Michael S Denison; Gilles J Guillemin; James B DuHadaway; George C Prendergast; Richard Metz; Michel Geffard; Louis Boon; Matteo Pirro; Alfonso Iorio; Bernard Veyret; Luigina Romani; Ursula Grohmann; Francesca Fallarino; Paolo Puccetti
Journal:  Nature       Date:  2014-07-10       Impact factor: 49.962

6.  Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

Authors:  Cristina L Swanson; Timothy J Wilson; Pamela Strauch; Marco Colonna; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

7.  Induction of apoptosis by the Bcl-2 homologue Bak.

Authors:  T Chittenden; E A Harrington; R O'Connor; C Flemington; R J Lutz; G I Evan; B C Guild
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

Review 8.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

9.  Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress.

Authors:  Tal I Arnon; Robert M Horton; Irina L Grigorova; Jason G Cyster
Journal:  Nature       Date:  2012-12-23       Impact factor: 49.962

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations.

Authors:  J Jacob; R Kassir; G Kelsoe
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  16 in total

1.  Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles.

Authors:  D Sharma; R Al-Khalidi; S Edgar; Q An; Y Wang; C Young; D Nowis; D C Gorecki
Journal:  Gene Ther       Date:  2016-12-22       Impact factor: 5.250

2.  Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.

Authors:  Mohamad El-Zaatari; Adam J Bass; Reanne Bowlby; Min Zhang; Li-Jyun Syu; Yitian Yang; Helmut Grasberger; Andrew Shreiner; Bei Tan; Shrinivas Bishu; Wai K Leung; Andrea Todisco; Nobuhiko Kamada; Marilia Cascalho; Andrzej A Dlugosz; John Y Kao
Journal:  Gastroenterology       Date:  2017-09-11       Impact factor: 22.682

3.  Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses.

Authors:  Shivana M Lightman; Jennifer L Peresie; Louise M Carlson; G Aaron Holling; Mackenzie M Honikel; Colin A Chavel; Michael J Nemeth; Scott H Olejniczak; Kelvin P Lee
Journal:  Immunity       Date:  2021-11-16       Impact factor: 43.474

4.  IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.

Authors:  Lauren M F Merlo; James B DuHadaway; Samantha Grabler; George C Prendergast; Alexander J Muller; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2016-04-25       Impact factor: 5.422

Review 5.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

6.  The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

Authors:  Mei-Ren Pan; Ming-Chuan Hsu; Chi-Wen Luo; Li-Tzong Chen; Yan-Shen Shan; Wen-Chun Hung
Journal:  Oncotarget       Date:  2016-09-20

7.  The Role and Mechanism of S1PR5 in Colon Cancer.

Authors:  Huijun Zhou; Xianli Yin; Fei Bai; Wu Liu; Shaofeng Jiang; Jinfeng Zhao
Journal:  Cancer Manag Res       Date:  2020-06-19       Impact factor: 3.989

Review 8.  Trial watch: Peptide-based vaccines in anticancer therapy.

Authors:  Lucillia Bezu; Oliver Kepp; Giulia Cerrato; Jonathan Pol; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

9.  Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans.

Authors:  Rahul Shinde; Kebria Hezaveh; Marie Jo Halaby; Andreas Kloetgen; Ankur Chakravarthy; Tiago da Silva Medina; Reema Deol; Kieran P Manion; Yuriy Baglaenko; Maria Eldh; Sara Lamorte; Drew Wallace; Sathi Babu Chodisetti; Buvana Ravishankar; Haiyun Liu; Kapil Chaudhary; David H Munn; Aristotelis Tsirigos; Michael Madaio; Susanne Gabrielsson; Zahi Touma; Joan Wither; Daniel D De Carvalho; Tracy L McGaha
Journal:  Nat Immunol       Date:  2018-05-14       Impact factor: 25.606

10.  Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.

Authors:  Lauren M F Merlo; James B DuHadaway; James D Montgomery; Wei-Dan Peng; Peter J Murray; George C Prendergast; Andrew J Caton; Alexander J Muller; Laura Mandik-Nayak
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.